Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras

Journal of Urology

Volumn 182, Issue 5, 2009, Pages 2242-2249

  Sun, Leon ^a   Caire, Arthur A ^a   Robertson, Cary N ^a   George, Daniel J ^a   Polascik, Thomas J ^a   Maloney, Kelly E ^a   Walther, Philip J ^a   Stackhouse, Danielle A ^a   Lack, Benjamin D ^a   Albala, David M ^a   Moul, Judd W ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

age factors; early detection of cancer; prostate specific antigen; survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE SEVERITY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SEMINAL VESICLE; TUMOR VOLUME; AGE; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; RISK FACTOR; SURVIVAL RATE;

AGE DISTRIBUTION; AGE FACTORS; AGED; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE;

EID: 70350468855     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.034     Document Type: Article

References (19)

1. Dong F., Reuther A.M., Magi-Galluzzi C., et al. Pathologic stage migration has slowed in the late PSA era. Urology 70 (2007) 839
2. Shikanov S.A., Thong A., Gofrit O.N., et al. Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters. J Endourol 22 (2008) 1477
3. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149 (2008) 185
4. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320
5. Andriole G.L., Crawford E.D., Grubb III R.L., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (2009) 1310
6. Thompson I., Thrasher J.B., Aus G., et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177 (2007) 2106
7. Smith R.A., Cokkinides V., and Brawley O.W. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 59 (2009) 27
8. Chun F.K., Briganti A., Graefen M., et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 52 (2007) 436
9. Richstone L., Bianco F.J., Shah H.H., et al. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram. BJU Int 101 (2008) 541
10. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98 (2006) 715
11. Schroeck F.R., Sun L., Freedland S.J., et al. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 11 (2008) 371
12. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
13. Loeb S., Hernandez D.J., Mangold L.A., et al. Progression after radical prostatectomy for men in their thirties compared to older men. BJU Int 101 (2008) 1503
14. Froehner M., Koch R., Litz R.J., et al. Survival analysis in men undergoing radical prostatectomy at an age of 70 years or older. Urol Oncol (2008)
15. Karakiewicz P.I., Benayoun S., Kattan M.W., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930
16. Kubricht W.S., Kattan M.W., Sartor O., et al. Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer. Urology 53 (1999) 553
17. Rodriguez-Covarrubias F., Larre S., De LaTaille A., et al. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy. BJU Int 101 (2008) 305
18. Magheli A., Rais-Bahrami S., Humphreys E.B., et al. Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol 178 (2007) 1933
19. Labrie F., Candas B., Cusan L., et al. Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial. Prostate 59 (2004) 311